Effect of captopril on the renal veno-arterial gradient of erythropoietin and oxygen in unilateral renal artery disease

References

• Milledge J S., Cotes P M. Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol 1985; 59: 360–4
   PubMed Web of Science ®Google Scholar
• Erslev A J., Wilson J, Caro J. Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 1987; 109: 429–33
   PubMed Web of Science ®Google Scholar
• Luke R G., Kennedy A C., Stirling W B., McDonald G A. Renal artery stenosis, hypertension, and poly-cythaemia. BMJ 1965; 1: 164–6
   PubMedGoogle Scholar
• Tarazi R C., Frohlich E D., Dustan H P., Gifford R W., Page I H. Hypertension and high haematocrit. Am J Cardiol 1966; 18: 855–8
   PubMedGoogle Scholar
• Wiecek A, Kokot F, Kuczera M, Grzeszczak W, Kiersztjen M. Plasma erythropoietin concentration in renal venous blood of patients with unilateral renovascular hypertension. Nephrol Dial Transplant 1992; 7: 221–4
   PubMed Web of Science ®Google Scholar
• Grützmacher P, Radtke H W., Schwab N, Schoeppe W. Erythropoietin secretion in patients with renal artery stenosis. Nephrol Dial Transplant 1988; 3: 496, [Abstract]
   Google Scholar
• Pagel H, Jellkmann W, Weiss C. A comparison of the effects of renal artery constriction and anemia on the production of erythropoietin. Pflugers Arch 1988; 413: 62–6
   PubMedGoogle Scholar
• Fisher J W., Samuels A I. Relationship between renal blood flow and erythropoietin production in dogs. Proc Soc Exp Biol Med 1967; 125: 482–5
   PubMedGoogle Scholar
• Pratt M C., Lewis-Barned N J., Walker R J., Bailey R R., Shand B I., Livesey J. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Pharmacol 1992; 34: 363–5
   Google Scholar
• Fyhrquist F, Karppinen K, Honkanen T, Saijon-maa O, Rosenlöf K. High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. J Int Med 1989; 226: 257–60
   PubMed Web of Science ®Google Scholar
• Kamper A L., Nielsen O J. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 1990; 50: 611–8
   PubMed Web of Science ®Google Scholar
• Annable L, Cotes P M., Mussett M V. The second international reference preparation of erythropoietin, human, urinary, for bioassay. Bull World Health Organ 1972; 47: 99–112
   PubMed Web of Science ®Google Scholar
• Giese J, Jørgensen M, Nielsen M D., Lund J O., Munck O. Plasma renin concentrations measured by use of a radioimmunoassay of angiotensin I. Scand J Clin Lab Invest 1970; 26: 355–68
   PubMed Web of Science ®Google Scholar
• McMahon F G., Vargas R, Ryan M, et al. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990; 76: 1718–22
   PubMed Web of Science ®Google Scholar
• Alexanian R. Urinary excretion of erythropoietin in normal men and women. Blood 1966; 28: 344–53
   PubMed Web of Science ®Google Scholar
• Kindler J, Eckardt K U., Ehmer B, et al. Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure. Nephrol Dial Transplant 1989; 4: 345–9
   PubMed Web of Science ®Google Scholar
• Jensen G, Björck S, Nielsen O J., Volkmann R, Aurell M. Diagnostic use of renal vein erythropoietin measurements in patients with renal artery stenosis. Nephrol Dial Transplant 1992; 7: 400–5
   PubMed Web of Science ®Google Scholar
• Pagel H, Jelkmann W, Weiss C. O2-supply to the kidneys and the production of erythropoietin. Respir Physiol 1989; 77: 111–8
   PubMedGoogle Scholar
• Nielsen K, Rehling M, Henriksen J H. Renal vein oxygen saturation in renal artery stenosis. Clin Physiol 1992; 12: 179–84
   PubMedGoogle Scholar
• Eckardt K, Kurtz A, Bauer C. Regulation of erythropoietin production is related to proximal tubular function. Am J Physiol 1989; 256: F942–F947
   Google Scholar
• Lassen N A., Munck O, Thaysen J H. Oxygen consumption and sodium reabsorption in the kidney. Acta Physiol Scand 1961; 51: 371–84
   PubMedGoogle Scholar
• Kramer K, Deetjen P. Beziehungen des O2-Verbrauchs der Niere zu Durchblutung und Glomerulusfiltrat bei Änderung des arteriellen Druckes. Pflugers Arch 1960; 271: 782–96
   Google Scholar
• Erslev A J., Caro J, Besarab A. Why the kidney?. Nephron 1985; 41: 213–6
   PubMedGoogle Scholar
• Wenting G J., Derkx F HM, Tan-Tjiong L H., Seyen A J., Veld A JMV., Schalekamp M ADH. Risks of angiotensin converting enzyme inhibition in renal artery stenosis. Kidney International 1987; 31(Suppl 20)S180–3
   Google Scholar
• Miyamori I, Yasuhara S, Matsubara T, Takasaki H, Takeda R. Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension. Am J Hypertens 1988; 1: 359–63
   PubMedGoogle Scholar
• Kurtz A, Eckardt K U., Tannahill L, Baur C. Regulation of erythropoietin production. Contrib Nephrol 1988; 66: 1–16
   PubMedGoogle Scholar
• Vlahakos D V., Canzanello V J., Madaio M P., Madias N E. Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis 1991; 17: 199–205
   PubMed Web of Science ®Google Scholar
• Gaston R S., Julian B A., Diethelm A G., Curtis J J. Effects of enalapril on erythrocytosis after renal transplantation. Ann Intern Med 1991; 115: 954–5
   PubMedGoogle Scholar
• Onyoyama K, Sanai T, Motumura K, Fusishima M. Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic haemodialysis patients. J Cardiovasc Pharmacol 1989; 13(suppl 3)S27–S30
   Google Scholar
• Gould A B., Goodman S, De Wolf R, Onesti G, Swartz C. Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 1980; 96: 523–34
   PubMed Web of Science ®Google Scholar
• Gould A B., Goodman S. Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats. Eur J Pharmacol 1990; 181: 225–34
   PubMedGoogle Scholar
• Carretero O A., Scicli A G. Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Hypertension 1991; 18(suppl I)I-58–I-69
   Google Scholar
• Labeeuw M, Prost N F., Daoud S, Lapra C, Zech P, Pozet N. Renal venous erythropoietin concentrations in hypertensive patients with unilateral renal disease. Nephrol Dial Transplant 1992; 7: 1190–3
   PubMedGoogle Scholar
• Fisher W F. Pharmacologic modulation of erythropoietin production. Ann Rev Pharmacol Toxicol 1988; 28: 101–22
   PubMedGoogle Scholar